By Diana Pankevich, Ph.D., director, innovation policy, Pfizer
Originally published in the Clinical Leader Guest Column, October 1, 2019
Now more than ever, patients are informed and active about their health. Technological advances are equipping patients with real-time health data. At-home genetic testing kits have the potential to reveal future health risks. And the internet can help increase health literacy and connect patients with other patients. These, and other tools, can empower patients to take control of their health while enhancing their ability to engage with the healthcare ecosystem. At the same time, there
are more patient-led efforts to create policies that are in line with patient interests to gain fair and equal access to treatments more quickly. Most of all, “Nothing about us, without us” is a consistent message that pharmaceutical companies, regulators, and others hear from patients.